Legal
Filter News
Found 8,972 articles
-
Chugai Renews License to EpiVax's ISPRI In Silico Toolkit for Immunogenicity Assessment
10/22/2019
ugai Pharmaceutical Co., Ltd., a member of the Roche Group, will extend the company's licensed access to the Immunogenicity Screening and Protein Reengineering Interface toolkit developed by EpiVax, Inc.
-
Teva Settles Track 1 Opioid Cases and Reaches Agreement on Framework to Settle Remaining Litigation
10/21/2019
Teva Pharmaceutical Industries Ltd. and its affiliates today announced a settlement agreement with both Cuyahoga and Summit counties of Ohio. The settlement resolves the counties’ claims and removes Teva from the Track 1 opioid litigation.
-
Henry Schein To Be Dismissed From Summit County Opioid Litigation
10/21/2019
Company to Make Donation to Establish Pain Management Education Foundation
-
Distributors Reach Settlement With Ohio Counties in Opioids Case
10/21/2019
AmerisourceBergen, Cardinal Health and McKesson announced this morning that they have agreed to a $215 million settlement with two Ohio counties, Cuyahoga and Summit, in the first track of the multi-district opioid litigation.
-
As an historic lawsuit over opioids was to enter court today, four key defendants reached a settlement.
-
Centrient Pharmaceuticals Initiates a Second Patent Litigation in India Against Dalas Biotech Limited
10/18/2019
Centrient Pharmaceuticals (“Centrient”), the global leader in the production and commercialisation of sustainable, enzymatic antibiotics, next generation statins and anti-fungals, announced that it has
-
Select Medical Corporation Comments on Settlement of Qui Tam Lawsuit in Evansville, Indiana
10/18/2019
Select Medical Corporation, commented on the settlement of a qui tam lawsuit filed in the United States District Court for the Southern District of Indiana against it, certain of its subsidiaries and an Evansville physician by three former employees of Select Specialty Hospital – Evansville, LLC SSH Evansville is a joint venture that operates a critical illness recovery hospital in Evansville, Indiana.
-
Parker Waichman LLP is Reviewing Talcum Powder Mesothelioma Cancer Cases
10/18/2019
Lawsuits Filed Over Contaminated Talcum Power Gain Momentum with New Study
-
J&J Close to Reaching $4 Billion Agreement to Settle Thousands of Opioid Lawsuits, Sources Say
10/17/2019
Citing “sources familiar with the matter,” The Wall Street Journal reported that the agreement, should it be reached, would ultimately settle the matter for the company related to sales of Duragesic and Nucynta. -
Netherlands-based Pharming Group NV has denied any involvement in a potential theft of intellectual property belonging to CSL Behring from Joseph Chiao, who recently joined Pharming as medical director.
-
China Biologic Special Committee Retains Financial Advisor and Legal Counsel
10/17/2019
China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the special committee (the "Special Committee") of the Company's board of directors (the "Board") has retained Duff & Phelps, LLC and Duff & Phelps Securities, LLC as its financial advisor and Davis Polk & Wardwell LLP
-
Moore Kuehn, PLLC Encourages Genomic Health, Inc. and Carbonite, Inc. Investors to Contact Firm
10/17/2019
Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City, is investigating potential claims involving the directors and officers regarding possible breaches of fiduciary duties and other violations of law related to merger agreements, inaccurate developments and/or financial projections.
-
AmerisourceBergen, McKesson and Cardinal Health are in the midst of negotiations for a multi-billion settlement over litigation filed against each of the companies for their role in distributing opioid drugs across the country.
-
PixarBio CEO Made Wild Claims About Curing Paralysis, According to a Former Executive's Testimony
10/16/2019
Frank Reynolds, chief executive officer of PixarBio, made outlandish claims to investors and even compared himself to Apple’s Steve Jobs and Jesus Christ. Those were the claims of a witness made on the witness stand in an ongoing securities fraud trial. -
Pharming responds to press speculation
10/16/2019
Pharming categorically denies having had any involvement in the alleged abstraction of proprietary information by Dr Joseph Chiao from his former employer CSL
-
ImmunoCellular Therapeutics Announces Settlement of Derivative Action Lawsuit
10/16/2019
The Court approved the settlement amount of one hundred forty-five thousand dollars ($145,000.00) to be paid by ImmunoCellular's insurer to Plaintiff's Counsel, and for a Service Award of one thousand dollars ($1,000.00) to be paid to Plaintiff from the Fee and Expense Award.
-
Los Angeles Court Rejects Patrick Soon-Shiong’s Attempt to Avoid Sorrento Litigation Allowing Arbitration Case to Move Forward
10/16/2019
Sorrento Therapeutics, Inc. announced today that a Los Angeles Superior Court judge has rejected Patrick Soon-Shiong’s attempt to allow him and his company, NantPharma, to avoid the billion-dollar fraud and breach of contract claims that Sorrento filed against them earlier this year.
-
Titan Medical Announces Filing of Amended and Restated Preliminary Prospectus and Withdrawal of Previously Published Milestones
10/15/2019
The A&R Preliminary Prospectus and Registration Statement are subject to completion and amendment.
-
MedX Holdings, Inc. (MEDH) Announces New Asset Acquisition
10/15/2019
MedX Holdings, Inc. is pleased to announce the acquisition of BioHydro LLC.
-
SCYNEXIS to Strengthen its Balance Sheet with Non-Dilutive Funding Through the New Jersey Economic Development Authority Net Operating Loss and R&D Tax Credits Program
10/10/2019
SCYNEXIS, Inc. has received notification from the State of New Jersey of its available unused net operating losses (NOLs) and R&D tax credits that can be sold under the New Jersey Economic Development Authority's (NJEDA) Technology Business Tax Certificate Transfer (NOL) program.